300194.SZ
Fuan Pharmaceutical (Group) Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 3.91
−0.51%Margins
Gross margin
36.8%
EBITDA margin
17.3%
EBIT margin
4.2%
Net margin
3.7%
FCF margin
16.7%
1.4%
Return on equity
1.1%
Return on assets
1.4%
Return on invested capital
0.29x
Asset turnover
CNY 369.9M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026